Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression

被引:103
作者
Hirshberg, B
Rother, KI
Digon, BJ
Lee, J
Gaglia, JL
Hines, K
Read, EJ
Chang, R
Wood, BJ
Harlan, DM
机构
[1] NIDDK, Transplantat & Autoimmun Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] NIH, Ctr Clin, Dept Transfus Med, US Dept HHS, Bethesda, MD 20892 USA
[3] NIH, Special Procedures Diagnost Radiol Dept, Dept Transfus Med, US Dept HHS, Bethesda, MD 20892 USA
关键词
D O I
10.2337/diacare.26.12.3288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The aim of this study was to describe the National Institutes of Health's experience initiating an islet isolation and transplantation center, including descriptions of our first six recipients, and lessons learned. RESEARCH DESIGN AND METHODS - Six females with chronic type 1 diabetes, hypoglycemia unawareness, and no endogenous insulin secretion (undetectable serum C-peptide) were transplanted with allogenic islets procured from brain dead donors. To prevent islet rejection, patients received daclizumab, sirolimus, and tacrolimus. RESULTS - All patients noted less frequent and less severe hypoglycemia and one-half were, insulin independent at 1 year. Serum C-peptide persists in all but one patient (follow-up 17-22 months), indicating continued islet function. Two major procedure-related complications occurred: partial portal vein thrombosis and intra-abdomin. at hemorrhage. While we observed no cytomegalovirus infection or malignancy, recipients frequently developed transient mouth ulcers, diarrhea, edema, hypercholesterolemia, weight loss, myelosuppression, and other symptoms. Three patients discontinued immunosuppressive therapy: two because of intolerable toxicity (deteriorating kidney function and sirolimus-induced pneumonitis) while having evidence for continued islet function (one was insulin independent) and one because of gradually disappearing islet function. CONCLUSIONS - We established an islet isolation and transplantation program and achieved a 50% insulin-independence rate after at most two islet infusions. Our experience demonstrates that centers not previously engaged in islet transplantation can initiate a program, and our data and literature analysis support not only the promise of islet transplantation but also its remaining hurdles which include the limited islet supply, procedure-associated complications, imperfect immunosuppressive regimens, suboptimal glycemia control, and toss of function over time.
引用
收藏
页码:3288 / 3295
页数:8
相关论文
共 31 条
  • [11] Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154
    Kenyon, NS
    Fernandez, LA
    Lehmann, R
    Masetti, M
    Ranuncoli, A
    Chatzipetrou, M
    Iaria, G
    Han, DM
    Wagner, JL
    Ruiz, P
    Berho, M
    Inverardi, L
    Alejandro, R
    Mintz, DH
    Kirk, AD
    Harlan, DM
    Burkly, LC
    Ricordi, C
    [J]. DIABETES, 1999, 48 (07) : 1473 - 1481
  • [12] Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
    Kenyon, NS
    Chatzipetrou, M
    Masetti, M
    Ranuncoli, A
    Oliveira, M
    Wagner, JL
    Kirk, AD
    Harlan, DM
    Burkly, LC
    Ricordi, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 8132 - 8137
  • [13] Kenyon NS, 1998, DIABETES METAB REV, V14, P303, DOI 10.1002/(SICI)1099-0895(199812)14:4<303::AID-DMR243>3.0.CO
  • [14] 2-E
  • [15] Cardiac transplantation: the final therapeutic option for the treatment of heart failure
    Koerner, MM
    Durand, JB
    Lafuente, JA
    Noon, GP
    Torre-Amione, G
    [J]. CURRENT OPINION IN CARDIOLOGY, 2000, 15 (03) : 178 - 182
  • [16] Evaluation of a purified enzyme blend for the recovery and function of canine pancreatic islets
    Lakey, JRT
    Cavanagh, TJ
    Zieger, MAJ
    Wright, M
    [J]. CELL TRANSPLANTATION, 1998, 7 (04) : 365 - 372
  • [17] Mortality trends in type 1 diabetes - The Allegheny County (Pennsylvania) Registry 1965-1999
    Nishimura, R
    LaPorte, RE
    Dorman, JS
    Tajima, N
    Becker, D
    Orchard, TJ
    [J]. DIABETES CARE, 2001, 24 (05) : 823 - 827
  • [18] AUTOMATED-METHOD FOR ISOLATION OF HUMAN PANCREATIC-ISLETS
    RICORDI, C
    LACY, PE
    FINKE, EH
    OLACK, BJ
    SCHARP, DW
    [J]. DIABETES, 1988, 37 (04) : 413 - 420
  • [19] ISLET ISOLATION ASSESSMENT IN MAN AND LARGE ANIMALS
    RICORDI, C
    GRAY, DWR
    HERING, BJ
    KAUFMAN, DB
    WARNOCK, GL
    KNETEMAN, NM
    LAKE, SP
    LONDON, NJM
    SOCCI, C
    ALEJANDRO, R
    ZENG, YJ
    SCHARP, DW
    VIVIANI, G
    FALQUI, L
    TZAKIS, A
    BRETZEL, RG
    FEDERLIN, K
    POZZA, G
    JAMES, RFL
    RAJOTTE, RV
    DICARLO, V
    MORRIS, PJ
    SUTHERLAND, DER
    STARZL, TE
    MINTZ, DH
    LACY, PE
    [J]. ACTA DIABETOLOGICA LATINA, 1990, 27 (03): : 185 - 195
  • [20] Pancreas and islet transplantation for patients with diabetes
    Robertson, RP
    Davis, C
    Larsen, J
    Stratta, R
    Sutherland, DER
    [J]. DIABETES CARE, 2000, 23 (01) : 112 - 116